Nausheen Ahmed - Concepedia

Author

Nausheen Ahmed

The University of Kansas Cancer Center ORCID

Also Known As

Ahmed, Nameer, Grover, Natalie S, Hill, Brian, N Ahmed, N. Ahmed, N. M. Ahmed, Nashwa Fathelrahman Elawad Ahmed, Nausheen Ahmed

380

Publications

4.5K

Citations

H-Index

Concepts

All Affiliations

The University of Kansas Cancer Center University of Kansas Medical Center Medical College of Wisconsin Cleveland Clinic Medical University of South Carolina

About

Nausheen Ahmed is an author at The University of Kansas Cancer Center specializing in medicine, immunotherapy, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	14	1.5K
2	Health Sciences	4	4	113
3	Cellular Therapies	4	4	139
4	Public Health	2	2	184
5	Allergy	1	1	11

Nausheen Ahmed

Publications

3.2K

Citations

H-Index

Page 1

	Year	Citations
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi, The Lancet Long CovidAntimicrobial StewardshipAntibioticsClinical InfectionPlatform Trial	2021	555
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet	2021	516
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet Covid-19 PandemicAntiviral TherapyClinical TrialsPlatform TrialMedicine	2022	382
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet	2021	289
Socioeconomic and Racial Disparity in Chimeric Antigen Receptor T Cell Therapy Access Nausheen Ahmed, Moazzam Shahzad, Ernie Shippey, Transplantation and Cellular Therapy Health Care DisparityImmunologyHealth DisparitiesTravel TimeSocial Determinants Of Health	2022	130
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet	2023	126
Prophylactic Tocilizumab Prior to Anti-CD19 CAR-T Cell Therapy for Non-Hodgkin Lymphoma Paolo F. Caimi, Gabriela Pacheco Sánchez, Ashish Sharma, Frontiers in Immunology ImmunologyImmune RegulationImmunoeditingCd4 T Cell ResponsesImmunotherapeutics	2021	109
Autologous transplant vs chimeric antigen receptor T-cell therapy for relapsed DLBCL in partial remission Mazyar Shadman, Marcelo C. Pasquini, Kwang Woo Ahn, Blood	2021	106
Patterns of Use, Outcomes, and Resource Utilization among Recipients of Commercial Axicabtagene Ciloleucel and Tisagenlecleucel for Relapsed/Refractory Aggressive B Cell Lymphomas Peter A. Riedell, Wei‐Ting Hwang, Loretta J. Nastoupil, Transplantation and Cellular Therapy Hematological MalignancyLymphoid NeoplasiaOncologyResource UtilizationCommercial Axicabtagene Ciloleucel	2022	75
Diagnostic MR imaging features of craniocerebral Aspergillosis of sino-nasal origin in immunocompetent patients Saad H. Bashir, Arshad Ali, Zarreen Sajjad, Acta Neurochirurgica Sino-nasal OriginCraniocerebral AspergillosisCraniofacial SurgeryCraniofacial DisorderImmunocompetent Patients	2005	72

Page 1